✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals

Themis Medicare Ltd.

THEMISMED

Market Cap
₹954 Cr.
P/E
0.00

Themis Medicare Ltd.

  • Themis Medicare
  • NGL Fine-Chem
  • Kopran
  • TJI Pharma - Small Cap
FAQs on Themis Medicare Ltd. Shareprice

Themis Medicare has given better returns compared to its competitors.
Themis Medicare has grown at ~17.49% over the last 7yrs while peers have grown at a median rate of 16.86%

Themis Medicare is expensive when considering the EV/EBIDTA, however latest PE is < 3 yr avg PE.
Latest PE of Themis Medicare is 0.0, while 3 year average PE is 26.51.
Also latest EV/EBITDA of Themis Medicare is 104 while 3yr average is 23.08.

View FAQ's On Business
Growth Table
  • Themis Medicare Ltd.
  • NGL Fine-Chem
  • Kopran
Balance Sheet
  • Themis Medicare Ltd.
  • NGL Fine-Chem
  • Kopran
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Themis Medicare Ltd.
  • NGL Fine-Chem
  • Kopran
Cash Flow
  • Themis Medicare Ltd.
  • NGL Fine-Chem
  • Kopran
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Themis Medicare Ltd.
  • NGL Fine-Chem
  • Kopran
Quarterly Results
  • Themis Medicare Ltd.
  • NGL Fine-Chem
  • Kopran
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Rhapson method.
Learn how to use Reverse DCF
FAQs on Themis Medicare Ltd. Financials

Balance sheet of Themis Medicare is strong.
It shouldn't have solvency or liquidity issues.

Yes, The net debt of Themis Medicare is increasing.
Latest net debt of Themis Medicare is ₹57.36 Crs as of Mar-25.
This is greater than Mar-24 when it was ₹57.23 Crs.

No, profit is decreasing.
The profit of Themis Medicare is -₹8.89 Crs for TTM, ₹29.83 Crs for Mar 2025 and ₹43.52 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Themis Medicare latest dividend payout ratio is 15.43% and 3yr average dividend payout ratio is 11.36%

Companies resources are allocated to majorly unproductive assets like Inventory

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech